Revenue
$372.1m
+1.1% ↑ vs $367.9m
Operating profit declined 13.6% as capex jumped 4.5x to $35.0m and a 41.3% effective tax rate widened the NPAT decline.
Revenue context before the current result.
Operating profit margin across covered periods.
Operating cash flow across covered periods.
Operating working-capital absorption or release by reporting period.
Key metrics
HY24 vs HY23
Revenue
$372.1m
+1.1% ↑ vs $367.9m
Net profit after tax
$33.2m
-27.2% ↓ vs $45.6m
Net cash inflow from operating activities
$38m
-19.1% ↓ vs $47m
Interim dividend per share
12.5c
+4.2% ↑ vs 12.0c
Operating profit
$60.5m
-13.6% ↓ vs $70m
Profit before tax
$56.6m
-10.7% ↓ vs $63.4m
Cash and cash equivalents
$131.8m
+35.0% ↑ vs $97.6m
Total assets
$680.2m
+2.8% ↑ vs $661.5m
What changed
Operating working capital released $2.9m against the supplied historical baseline where two of three prior comparable periods built working capital, averaging $14.7m of build; that tailwind could not offset the operating decline, and operating cash inflow still fell to $38.0m from $47.0m.
Capex rose to $35.0m from $7.7m (9.4% of revenue versus 2.1%), pushing pre-lease free cash flow to $3.0m against the company's historical mean of $27.7m and the prior comparable $39.4m. The effective tax rate moved to 41.3% from 28.1% (historical baseline mean 28.3%, range 28.1%–28.6%), widening the gap between PBT ($56.6m versus $63.4m) and NPAT ($33.2m versus $45.6m). Cash on the balance sheet rose to $131.8m from $97.6m, and the interim dividend component was 12.5cps versus 12.0cps.
What matters
With revenue moving only modestly higher in dollar terms, operating leverage worked against earnings: operating profit fell $9.5m while revenue rose roughly $4.1m. This is the core operating read.
Pre-lease FCF of $3.0m sits well below the supplied historical mean of $27.7m, with the $27.3m capex step-up the proximate driver. Without disclosure of whether this is a one-off programme or a sustained higher run rate, the path back to historical FCF levels is unclear, which matters because dividend cash coverage and balance-sheet flexibility depend on it.
The effective tax rate of 41.3% sits well outside the supplied historical baseline range of 28.1%–28.6% and accounts for roughly 16.5 percentage points of the gap between PBT and NPAT direction. PBT is the cleaner operating read this half. Period-on-period growth percentages for revenue, PBT and NPAT carry a basis-discontinuity caveat, so absolute dollar movements are the more reliable comparison.
Expectations
Annualised current revenue is $744.2m, below FY23's $785.9m. With gross margin compressed and capex elevated, extrapolating H1 would imply a step-down in full-year earnings versus FY23 unless second-half gross margin or operating leverage improves.
No forward target or guidance was supplied, and the release does not provide commentary on second-half capex, margin recovery, or tax rate normalisation. The H1 trajectory is the only available reference point.
Quality of result
Inventory fell to $106.3m from $113.0m (52.0 days versus 55.9 days, within the supplied historical range of 51.3–55.9 days), which helps cash but raises the question of whether clearance activity contributed to the gross margin compression.
The more visible quality issue is cash earnings: pre-lease FCF coverage of NPAT fell to 9.2% from 86.4% as capex moved from $7.7m to $35.0m. That is a material deterioration in cash earnings irrespective of the merit of the investment programme. The 41.3% effective tax rate, above the supplied historical baseline range of 28.1%–28.6%, further weakens NPAT as a measure of underlying earnings. PBT moving from $63.4m to $56.6m, alongside operating profit down 13.6%, are the cleaner reads.
Unresolved
This briefing cannot assess management's strategic intent behind the elevated capex, the composition of the elevated tax charge, or the durability of the H1 working-capital release.
Chat
Ask follow-up questions about Briscoe Group's HY24 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load segment breakdown.
Open to load analytical metrics.
Open to load key metrics.
BGP - HY July 2024 Financial Statements & Independent Auditors Review Report
HY24 / financial reportBGP - HY July 2024 Results Announcement
HY24 / results announcementBGP - HY July 2024 Results Commentary
HY24 / results releaseBGP HY July 2022 Financial Statements and Independent Auditors Review Report
HY23 / financial reportBGP HY July 2022 Results Announcement
HY23 / results announcementBGP HY July 2022 Results Commentary
HY23 / results releaseBGP- Annual Report 29 January 2023
FY23 / financial reportBGP Addresses to Annual Meeting 19 May 2022
HY23 / commentaryBGP - Addresses to Annual Meeting 16 May 2024
HY24 / commentaryRelated insights
Cross-company views selected from the metrics in this briefing.
Earnings quality and statutory distortions
PBT and NPAT growth diverged by 16.5pp, with a distortion flag in the result.
Dividend coverage and payout pressure
Dividend payout versus NPAT is 83.8%.
ROE and capital efficiency
ROE was 11.1%, -4.0pp versus the prior comparable period.
Revenue growth context
Revenue growth was 1.1% for this reporting period.
Get the next Briscoe Group briefing and related NZX reporting-season updates by email.